Show
Sort by
-
- Journal Article
- A1
- open access
European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer
-
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
-
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer : the pathologists' perspective
-
Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up
-
Man against machine reloaded : performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
-
A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
-
The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality
-
Splenic metabolic activity as biomarker in cervical cancer
-
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial
-
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees